http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2093630-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97ddd4d1d0ebc8a7d2c8e7d214d08cf3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 1992-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3ea405ca0a7f12c000d4750d4eb2ddb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cf671cbaffa3c74c7202262cf80958e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb21cccd116b6f232b9fa9ea9133d37f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65e17f7464c43698974ca3592c28bc52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6300a72a477b9b2ee1c53f63d1fb84ab |
| publicationDate | 2004-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2093630-C |
| titleOfInvention | Pyrroloazepine compound |
| abstract | This invention provides a pyrroloazepine compound represented by the following Formula (I) or (II): (see formula I and II) wherein, when the bond indicated by the dashed line is present, Z1 represents H but, when the bond indicated by the dashed line is absent, Z1 represents H and Z2 represents OH or Z1 and Z2 are taken together to form O or a group NOR1, R1 representing H or an alkyl, aryl or aralkyl group; R represents an alkyl, cycloalkyl, cycloalkyl-alkyl, aryl, or aralkyl group; A represents an alkylene, alkenylene or alkynylene group; and Y represents a substituted or unsubstituted heterocyclic group or a group: (see formula III) in which R2 and R3 represent H or an alkyl, a lower-alkoxy- or aryloxy-substituted alkyl, aryl or aralkyl group; a salt thereof; a preparation process thereof and a therapeutic for circulatory diseases, said therapeutic containing as an active ingredient the pyr-roloazepine derivative or the salt thereof. |
| priorityDate | 1991-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 279.